132 related articles for article (PubMed ID: 37284107)
1. Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma.
Yu H; Gao L; Shi R; Kong M; Duan L; Cui J
Quant Imaging Med Surg; 2023 Jun; 13(6):3716-3725. PubMed ID: 37284107
[TBL] [Abstract][Full Text] [Related]
2. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results.
Baunin C; Schmidt G; Baumstarck K; Bouvier C; Gentet JC; Aschero A; Ruocco A; Bourlière B; Gorincour G; Desvignes C; Colavolpe N; Bollini G; Auqier P; Petit P
Skeletal Radiol; 2012 Sep; 41(9):1141-9. PubMed ID: 22318350
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
Tepe M; Saylisoy S; Toprak U; Inan I
Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
[TBL] [Abstract][Full Text] [Related]
4. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899
[TBL] [Abstract][Full Text] [Related]
5. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
[No Abstract] [Full Text] [Related]
6. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
[TBL] [Abstract][Full Text] [Related]
7. Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.
Yin P; Xu J; Sun X; Liu T; Chen L; Hong N
Eur J Radiol; 2023 May; 162():110790. PubMed ID: 36963332
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis.
Baidya Kayal E; Bakhshi S; Kandasamy D; Sharma MC; Khan SA; Kumar VS; Khare K; Sharma R; Mehndiratta A
J Transl Med; 2022 Dec; 20(1):625. PubMed ID: 36575510
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
11. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy.
Fu C; Bian D; Liu F; Feng X; Du W; Wang X
Int J Gynecol Cancer; 2012 Jul; 22(6):1037-43. PubMed ID: 22683941
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study.
Wang CS; Du LJ; Si MJ; Yin QH; Chen L; Shu M; Yuan F; Fei XC; Ding XY
PLoS One; 2013; 8(8):e72679. PubMed ID: 23991141
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.
Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
Eur J Radiol; 2019 Oct; 119():108635. PubMed ID: 31445487
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
Li QW; Qiu B; Wang B; Wang DL; Yin SH; Yang H; Liu JL; Fu JH; Liu MZ; Xie CM; Liu H
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036528
[TBL] [Abstract][Full Text] [Related]
15. Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.
Wang J; Sun M; Liu D; Hu X; Pui MH; Meng Q; Gao Z
Acta Radiol; 2017 Aug; 58(8):971-976. PubMed ID: 27852643
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
17. T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.
Baidya Kayal E; Sharma N; Sharma R; Bakhshi S; Kandasamy D; Mehndiratta A
Eur J Radiol; 2022 Mar; 148():110170. PubMed ID: 35086004
[TBL] [Abstract][Full Text] [Related]
18. Nomogram based on quantitative dynamic contrast-enhanced magnetic resonance imaging, apparent diffusion coefficient, and clinicopathological features for early prediction of pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy.
He M; Su J; Ruan H; Song Y; Ma M; Xue F
Quant Imaging Med Surg; 2023 Jul; 13(7):4089-4102. PubMed ID: 37456283
[TBL] [Abstract][Full Text] [Related]
19. Can the ADC Value Be Used as an Imaging "Biopsy" in Endometrial Cancer?
Petrila O; Nistor I; Romedea NS; Negru D; Scripcariu V
Diagnostics (Basel); 2024 Feb; 14(3):. PubMed ID: 38337842
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
Liu C; Xi Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Korean J Radiol; 2019 May; 20(5):801-811. PubMed ID: 30993931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
